2) Acute myeloid leukemia with recurrent genetic abnormalities Flashcards
Acute myeloid leukemia with recurrent genetic abnormalities
AML with
a. t (8;21) (q22; q22)
b. t(15;17) (q22;q12)
a. t (8;21) (q22; q22)
AML with abnormal bone marrow eosinophils inv\
a.inv(16)p13q22
b. t(16;16)(p13;q22)
c. t(15;17) (q22;q12) and variants
a.inv(16)p13q22
b. t(16;16)(p13;q22)
Acute promyelocytic leukemia
a. 11q23 abnormalities
b.. t(15;17) (q22;q12) and variants
b.. t(15;17) (q22;q12) and variants
**AML with **
a. 1q23 abnormalities
b.1q24 abnormalities
a. 1q23 abnormalities
AML with t(8;21) (q22;q22)
a. 5%-10% of AML
cases
b. 10% of AML cases
c. 5% of AML
d.
a. 5%-10% of AML
cases
10% of AML cases
a. ML with inv (16) (p13q22)
b. t(16;16) (p13;q22)
c. t(15;17) (q22;q12
d. ML with 11q23 abnormalities
a. ML with inv (16) (p13q22)
5% of AMl
a. ML with inv (16) (p13q22)
b. t(16;16) (p13;q22)
c. t(15;17) (q22;q12 acute promyelocytic
leukemia
d. ML with 11q23 abnormalities
d. ML with 11q23 abnormalities
c. t(15;17) (q22;q12
predominantly
younger patients
a. AML with t(8;21) (q22;q22)
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22)
c. AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
d.AML with 11q23 abnormalities
a. AML with t(8;21) (q22;q22)
occurs at any age,but more
common among children
a. AML with t(8;21) (q22;q22)
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22)
c. AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
d.AML with 11q23 abnormalitie
d.AML with 11q23 abnormalitie
blasts – typically
large, with abundant
basophilic cytoplasm, often
with Auer rods and numerous,
sometimes very large azurophilic
granules
a. AML with t(8;21) (q22;q22)
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22)
c. AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
d.AML with 11q23 abnormalities
a. AML with t(8;21) (q22;q22)
** abnormal
promyelocytes are
present, either
hypergranular or
hypogranular
(microgranular)**
a.AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22
c. AML with t(8;21) (q22;q22)
d.AML with 11q23 abnormalities
a.AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
The bone marrow
usually has elements
of both granulocytic
and monocytic
differentiation
combined with
abnormal eosinophils
a.AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22
c. AML with t(8;21) (q22;q22)
d.AML with 11q23 abnormalities
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22
** monocytic differentiation,
with monoblasts and
promonocytes
predominating, is the most
common morphologic
pattern**
a.AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22
c. AML with t(8;21) (q22;q22)
d.AML with 11q23 abnormalities
d.AML with 11q23 abnormalities
M4eo in FAB
classification or
acute myelomonocytic
leukemia with
abnormal eosinophils
a.AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22
c. AML with t(8;21) (q22;q22)
d.AML with 11q23 abnormalities
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22
M3 or M3v in FAB classification
a.AML with t(15;17) (q22;q12)
or acute promyelocytic
leukemia
b. AML with inv (16) (p13q22) or
t(16;16) (p13;q22
c. AML with t(8;21) (q22;q22)
d.AML with 11q23 abnormalities
a.AML with t(15;17) (q22;q12)